These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 36278951)

  • 1. A review of transthyretin cardiac amyloidosis.
    Jhawar N; Moreno JCL; Chirila R
    Rom J Intern Med; 2023 Mar; 61(1):28-34. PubMed ID: 36278951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transthyretin Cardiac Amyloidosis: An Evolution in Diagnosis and Management of an "Old" Disease.
    Smiley DA; Rodriguez CM; Maurer MS
    Cardiol Clin; 2022 Nov; 40(4):541-558. PubMed ID: 36210137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable.
    Rubin J; Maurer MS
    Annu Rev Med; 2020 Jan; 71():203-219. PubMed ID: 31986086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiology and treatment of cardiac amyloidosis.
    Gertz MA; Dispenzieri A; Sher T
    Nat Rev Cardiol; 2015 Feb; 12(2):91-102. PubMed ID: 25311231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transthyretin cardiac amyloidosis: an update on diagnosis and treatment.
    Yamamoto H; Yokochi T
    ESC Heart Fail; 2019 Dec; 6(6):1128-1139. PubMed ID: 31553132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac amyloidosis: a practical approach to diagnosis and management.
    Kapoor P; Thenappan T; Singh E; Kumar S; Greipp PR
    Am J Med; 2011 Nov; 124(11):1006-15. PubMed ID: 22017778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standardising Care and Treatment of Transthyretin Amyloid Cardiomyopathy.
    Fontana M; Porcari A; Hawkins PN
    Glob Heart; 2023; 18(1):63. PubMed ID: 38028963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in the diagnosis and management of cardiac amyloidosis.
    Sher T; Gertz MA
    Future Cardiol; 2014 Jan; 10(1):131-46. PubMed ID: 24344669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progress in the diagnosis and treatment of cardiac amyloidosis].
    Jurczyszyn A; Engel A; Rajzer M; Czepiel J; Mazurs G
    Przegl Lek; 2014; 71(6):340-5. PubMed ID: 25344976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac amyloidosis: updates in diagnosis and management.
    Mohty D; Damy T; Cosnay P; Echahidi N; Casset-Senon D; Virot P; Jaccard A
    Arch Cardiovasc Dis; 2013 Oct; 106(10):528-40. PubMed ID: 24070600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in the diagnosis and treatment of transthyretin amyloid cardiomyopathy.
    Vaishnav J; Brown E; Sharma K
    Prog Cardiovasc Dis; 2024; 82():113-124. PubMed ID: 38246305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac amyloidosis: an approach to diagnosis and management.
    Halwani O; Delgado DH
    Expert Rev Cardiovasc Ther; 2010 Jul; 8(7):1007-13. PubMed ID: 20602561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac amyloidosis: approaches to diagnosis and management.
    Desai HV; Aronow WS; Peterson SJ; Frishman WH
    Cardiol Rev; 2010; 18(1):1-11. PubMed ID: 20010333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Misconceptions and Facts About Cardiac Amyloidosis.
    Nguyen FD; Rodriguez M; Krittanawong C; Witteles R; Lenihan DJ
    Am J Cardiol; 2021 Dec; 160():99-105. PubMed ID: 34610875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding and recognizing cardiac amyloidosis.
    McVeigh T; Tennyson C
    JAAPA; 2020 Oct; 33(10):16-20. PubMed ID: 32941304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transthyretin Amyloid Cardiomyopathy-Current and Future Therapies.
    Yadav JD; Othee H; Chan KA; Man DC; Belliveau PP; Towle J
    Ann Pharmacother; 2021 Dec; 55(12):1502-1514. PubMed ID: 33685242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology and clinical manifestations of cardiac amyloidosis.
    Bajwa F; O'Connor R; Ananthasubramaniam K
    Heart Fail Rev; 2022 Sep; 27(5):1471-1484. PubMed ID: 34694575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Practical guidelines for the diagnosis and treatment of transthyretin amyloid cardiomyopathy (ATTR-CM or transthyretin cardiac amyloidosis)].
    Tereshchenko SN; Zhirov IV; Moiseeva OM; Adasheva TV; Ansheles AA; Barbarash OL; Galyavich AS; Gudkova AI; Zateyshchikov DA; Kostareva AA; Nasonova SN; Nedogoda SV; Pecherina TB; Ryzhkova DV; Sergienko VB
    Ter Arkh; 2022 May; 94(4):584-595. PubMed ID: 36286812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transthyretin amyloid cardiomyopathy.
    Garcia-Pavia P; Domínguez F; Gonzalez-Lopez E
    Med Clin (Barc); 2021 Feb; 156(3):126-134. PubMed ID: 33138983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Arrhythmias and amyloidosis].
    Papathanasiou M; Schlender LS; Johnson VL; Wakili R
    Herzschrittmacherther Elektrophysiol; 2024 Sep; 35(3):199-204. PubMed ID: 38740607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.